Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Biological Chemistry

Amyloid-β Gets Toxic Helping Hand

Alzheimer’s peptide needs another pyroglutamate-modified peptide to misfold and eventually cause nerve cell death

by Lauren K. Wolf
May 7, 2012 | A version of this story appeared in Volume 90, Issue 19

[+]Enlarge
Credit: Nature
A small amount (5%) of pyroglutamylated amyloid-β helps unmodified amyloid-β kill a significant number of neurons (fluorescently labeled, right), but amyloid-β by itself leaves the cells intact (left).
A small amount (5%) of pyroglutamylated amyloid- ß helps unmodified amyloid- ß kill a significant number of neurons (fluorescently labeled, right), but amyloid- ß by itself leaves the cells intact (left).
Credit: Nature
A small amount (5%) of pyroglutamylated amyloid-β helps unmodified amyloid-β kill a significant number of neurons (fluorescently labeled, right), but amyloid-β by itself leaves the cells intact (left).

Amyloid-β, the peptide that misfolds and then forms plaques in the brains of Alzhei­mer’s patients, likely misfolds with help from a less prevalent, modified version of itself, according to a report in Nature (DOI: 10.1038/nature11060). Scientists have suspected that forms of amyloid-β modified with an amino-terminal pyroglutamate trigger unmodified amyloid to misfold, but they haven’t been sure of the mechanism for this interaction. On the basis of in vitro studies in neurons, George S. Bloom of the University of Virginia; Hans-Ulrich Demuth of Probiodrug, a biopharma firm in Germany; and coworkers propose that pyro­glutamylated amyloid-β (pE-Aβ), which readily folds into a toxic form, acts as a template for amyloid-β, helping to convert it into a more dangerous oligomeric form. By itself, a 42-residue version of amyloid-β had almost no effect on neurons to which it was added for 12 hours. But an oligomerized mixture of 95% amyloid-β and 5% 39-residue pE-Aβ killed about 60% of neurons over the same period. The team also showed that pE-Aβ needs tau protein, another macromolecule implicated in Alzheimer’s, to kill nerve cells. In mice engineered to lack tau and to overproduce pE-Aβ, neurons remained intact for at least three months.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.